CandiRoqSAN (sanPharma GmbH)


Welcome to the PulseAid listing for the CandiRoqSAN drug offered from sanPharma GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: sanPharma GmbH
NON-PROPRIETARY NAME: CANDIDA PARAPSILOSIS and PENICILLIUM ROQUEFORTI
SUBSTANCE NAME: CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: RECTAL
DOSAGE FORM: SUPPOSITORY
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-01-07
END MARKETING DATE: 0000-00-00


CandiRoqSAN HUMAN OTC DRUG Details:

Item DescriptionCandiRoqSAN from sanPharma GmbH
LABELER NAME: sanPharma GmbH
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3([hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2017-01-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64232-045_ca2e4ff9-981c-47e0-9f1b-a1aede46079a
PRODUCT NDC: 64232-045
APPLICATION NUMBER:

Other CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
sanPharma GmbHCandiRoqSAN